For many years, Telstra Corporation Ltd (ASX: TLS) has been a stalwart in investors’ portfolios for its reliable and juicy dividend, especially those looking for income such as retirees.
However, in the 2017-18 financial year Telstra slashed its dividend citing earnings headwinds from the NBN as it lost some of its competitive advantage which has been previously detailed here. Telstra’s dividend was cut by 29% from 31 cents per share (cps) to just 22cps in FY18. The share price too has fallen from $5.10 at the start of 2017, to a low of $2.57 in June 2018.
Will Telstra Lose Other Competitive Advantages?
One other advantage Telstra has had for a long time is that it boasts the superior mobile network in the country which competitors such as Optus, TPG Telecom Ltd (ASX: TPM), Vocus Group Ltd (ASX: VOC) and Vodafone Australia or Hutchinson Telecommunications Ltd (ASX: HTA) have not been able to compete with in terms of quality or reliability.
Part of the reason for Telstra’s dominance is due to its financial firepower or reliable cash flows which have been used to invest in mobile infrastructure that its competitors simply could not match.
Will There Be Another Mobile Competitor?
Aside from Optus and Vodafone Australia, TPG looms as a potential competitor in the mobile space that must be respected, especially if a joint venture with Vodafone Australia is given the green light by the ACCC. Or will TPG take its bat and ball and refuse to play?
Dividends Forecast To Be Cut
Telstra chief executive Andy Penn previously said Telstra would move away from a 100% dividend payout ratio to a range between 70% and 90%. Analysts are expecting earnings to decline over the next few years so investors should also expect the dividend to follow suit. Morningstar has a forecast dividend of 15.9cps.
After searching through a market with over 2,000 shares, our lead expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).